Date:2/7/2013

pan>China's Health Reform: EMS and Reform of Publicly Funded Hospitals 273.7 Evolving Trends in the Healthcare System in China 283.7.1 Increase in Taiwanese Investment in Hospitals in China 283.7.2 Hospital Advertising 284 Pricing and Reimbursement in China - Overview 294.1 Pharmaceuticals in Healthcare Systems in China 294.1.1 OTC Drug Market in China 295 Pricing and Reimbursement in China - Pricing 315.1 Drug Pricing Mechanism 315.1.1 Pricing of List A Drugs 325.1.2 Pricing of List B Drugs 325.1.3 Principles for Government Pricing: 335.1.4 NDRC Drug Pricing: Criteria for Evaluation 345.1.5 Objectives for Drug Price Regulation in China 355.2 National Essential Medicines List (NEML) 355.2.1 National Essential Medicines List - 2009 365.2.2 Essential Drugs List (2000 - 2009) 375.2.3 NEML 2009 Continues to Focus on Affordability and Accessibility 385.3 Drug Regulation Pattern 395.3.1 Key Reasons for High Drug Price in China 395.3.2 Differential Drug Pricing 395.3.3 Pricing Premiums 405.3.4 Foreign Drugs Exempt from Price Cuts 405.3.5 Drug Pricing Trends Closely Followed by R&D-Based Pharmaceutical Companies 405.4 Drug Registration Process 415.4.1 Classification of Drugs 415.4.2 New Drug Registration Process: 425.4.3 Negative Pricing Pressures Not Effective in Stemming Healthcare Expenditures 435.4.4 Challenges Facing Pricing and Reimbursement in China 456 Pricing and Reimbursement in China - Reimbursement Scenario 466.1 Health Insurance in China 466.1.1 Urban Health Insurance 476.1.2 Rural Health Insurance 476.1.3 Private Insurance 486.1.4 Private Insurance Sector is Thriving 496.1.5 Universal Health Insurance Coverage 496.2 Drug Reimbursement in China
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
2. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
3. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
4. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
5. KaloBios Pharmaceuticals Completes Initial Public Offering
6. As Type 2 Diabetes Grows at Alarming Rates, Pharmaceutical Companies Will Face New Challenges and New Opportunities
7. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
8. Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference
9. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
10. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Requirements
11. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th